Patent · US Active

Process for the preparation of HMG-COA reductase inhibitors and intermediates thereof

US8476432B2 · kind B2 · utility

3Cited by
9References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 2011
Grant dateJul 2, 2013
Priority date
Expiry dateJun 30, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides an improved process for preparing HMG-CoA reductase inhibitors such as rosuvastatin calcium, fluvastatin sodium, and pitavastatin calcium under a mild condition, using a novel amide-bond-containing compound having R2—N—O—R1 moiety as a key intermediate. And also, the present invention provides the novel compound, an intermediate useful for the preparation thereof, and a process for the preparation thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.